Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Aravive, Inc. (ARAV) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
08/25/2023 ARS Form ARS - Annual Report to Security Holders:
08/24/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/21/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/02/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ...
05/25/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " ",
" "
05/16/2023 8-K Investor presentation
Docs: " ",
" "
04/19/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/15/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: " "
03/15/2023 10-K Annual Report for the period ended December 31, 2022
02/28/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
02/14/2023 SC 13G BAKER BROS. ADVISORS LP reports a 7.5% stake in Aravive, Inc.
02/13/2023 8-K Quarterly results
02/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: " ",
" ",
" ",
" "
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 HOWARD RUDY (CFO) has filed a Form 4 on Aravive, Inc.
Txns: Granted 400,000 options to buy @ $1.67, valued at $668k
02/02/2023 4 Dove Leonard Scott (COO) has filed a Form 4 on Aravive, Inc.
Txns: Granted 400,000 options to buy @ $1.67, valued at $668k
01/18/2023 8-K Quarterly results
01/04/2023 8-K Quarterly results
01/03/2023 8-K Quarterly results
01/03/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/28/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/27/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/30/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
11/29/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/29/2022 8-K Quarterly results
11/29/2022 EFFECT Form EFFECT - Notice of Effectiveness:
11/18/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
11/17/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
11/16/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Aravive, Inc. press release"
11/07/2022 SC 13G BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in Aravive, Inc.
11/03/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy